ARCHIVES

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

November 28, 2014

Report to the Nation: Death Rates Continue To Decline Across All Major Disease Sites

January 3, 2014

CDC Funds Early Detection Programs In Eight States

August 23, 1991

Pancreatic Cancer Research To Increase, Institute Says.

November 16, 2001

Tobacco Control: Surgeon General Finds Increase In Smoking By Minority Teens

May 1, 1998

Higher Tobacco Tax Will Save Lives, Groups Tell Clinton, congress

January 22, 1993